Detalhe da pesquisa
1.
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Future Oncol
; 19(10): 727-736, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133230
2.
Identifying Knowledge and Practices regarding Cancer Patient Malnutrition: A Survey Study among Oncologists.
Nutr Cancer
; 74(7): 2392-2399, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856863
3.
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Anticancer Drugs
; 33(7): 663-670, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35703239
4.
Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group.
J Cancer Res Clin Oncol
; 148(12): 3547-3555, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689097
5.
A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).
J BUON
; 24(1): 136-142, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30941962